EuBiologics Statistics

Total Valuation

EuBiologics has a market cap or net worth of KRW 465.49 billion. The enterprise value is 462.23 billion.

Market Cap	465.49B
Enterprise Value	462.23B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

EuBiologics has 36.62 million shares outstanding.

Current Share Class	36.62M
Shares Outstanding	36.62M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	4.08%
Float	29.28M

Valuation Ratios

The trailing PE ratio is 18.72 and the forward PE ratio is 10.12.

PE Ratio	18.72
Forward PE	10.12
PS Ratio	4.85
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	18.59
EV / Sales	4.81
EV / EBITDA	n/a
EV / EBIT	13.47
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.08B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.55% in the last 52 weeks. The beta is 0.52, so EuBiologics's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+13.55%
50-Day Moving Average	12,859.00
200-Day Moving Average	12,605.10
Relative Strength Index (RSI)	46.64
Average Volume (20 Days)	129,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EuBiologics had revenue of KRW 96.04 billion and earned 24.87 billion in profits.

Revenue	96.04B
Gross Profit	96.04B
Operating Income	34.32B
Pretax Income	23.78B
Net Income	24.87B
EBITDA	n/a
EBIT	34.32B
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 35.74% and 25.89%.

Gross Margin	100.00%
Operating Margin	35.74%
Pretax Margin	24.77%
Profit Margin	25.89%
EBITDA Margin	n/a
EBIT Margin	35.74%
FCF Margin	n/a

Dividends & Yields

EuBiologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.13%
Shareholder Yield	n/a
Earnings Yield	5.34%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3